Digestion matters.
The way nutrients are broken down earlier in the gastrointestinal tract helps determine what remains available later.
Tharos studies the relationship between digestion, nutrient breakdown and the microbial environment of the gut. Our starting point is not simply which microorganisms are present, but what nutritional environment they are being given.
Nutrients entering the gastrointestinal tract are transformed as digestion takes place. Those processes affect the substrates that remain available further downstream — and therefore the environment encountered by microbial communities.
The way nutrients are broken down earlier in the gastrointestinal tract helps determine what remains available later.
Microbial communities depend upon the nutrients and compounds available within their environment.
Change the nutritional conditions experienced by an existing microbial community and the community can respond.
The sections below explore the idea in more detail — beginning with why simply describing which bacteria are present tells only part of the microbiome story.
Microbiome analysis often begins by identifying which microorganisms are present and their relative abundance. That information can be valuable — but composition alone does not describe the entire biological system.
Sequencing and other microbiome techniques can help describe the microorganisms present within a sample and how abundant different groups appear to be.
Microorganisms interact with the substrates available within their environment. Their activity, the compounds they use and the products of microbial metabolism add another layer to understanding the system.
Which microorganisms are present, how diverse the community appears to be and how relative abundance differs between samples.
The nutrients and compounds that reach microbial communities provide the material on which microbial activity depends.
The compounds produced as microorganisms interact with available substrates can provide information about what is occurring within that environment.
The material available to microbial communities is partly determined by what happens earlier in digestion. Nutrients may be broken down, absorbed, transformed or passed further along the gastrointestinal tract.
That means the microbial environment is connected to the digestive processes occurring upstream. Change the way nutrients are processed and the substrate arriving downstream can also change.
Anabiomics takes a substrate-led view of the microbiome. Rather than beginning with the assumption that a desired microbial community must be introduced, the approach asks how digestion and nutrition influence the environment experienced by the microbial community already present.
To understand how Tharos applies this thinking, we need to look at digestion itself — particularly the role of digestive enzymes in determining how nutrients are processed before they reach microbial communities further downstream.
Diet, digestion and nutrient availability continually shape the environment in which microbial communities operate.
Food does not arrive at microbial communities unchanged. Along the way, digestive processes break nutrients down, transform them and influence what remains available further downstream. Enzyme activity is part of that upstream process.
Digestive enzymes are selective. Different enzymes act on different components of food, helping transform complex nutritional material into smaller molecules and altered substrates. The pattern of enzyme activity therefore contributes to determining what is processed earlier and what continues through the digestive system.
Amylase helps break starch molecules into smaller carbohydrate components, influencing how dietary starch is processed through the digestive system.
Fructanase acts on fructan carbohydrates found in plant material, helping alter the way these compounds are presented to the wider digestive system.
Cellulase acts on cellulose, one of the structural carbohydrate components of plant cell walls, contributing to the wider breakdown of plant material.
Xylanase targets xylan-containing components of plant cell walls, helping modify complex plant material during the digestive process.
Beta-glucanase acts on beta-glucan carbohydrates present in cereal and plant material, contributing to their enzymatic breakdown.
Phytase acts on phytate, a plant compound capable of binding phosphorus and other minerals, changing how those nutrients are associated within feed.
Proteases break larger proteins into smaller peptides and amino-acid-containing fragments as part of protein digestion.
Lipase acts on dietary fats, helping break triglycerides into smaller lipid components during digestion.
Different parts of the gastrointestinal tract perform different jobs. In animals such as the horse, microbial fermentation remains fundamental to the utilisation of fibrous plant material.
The Tharos approach is therefore not about trying to move every digestive process upstream. It is about recognising that enzymatic digestion and microbial fermentation are connected stages within the same nutritional system.
Malted barley naturally develops a broad range of enzymes as part of the germination process. Tharos' work has focused on an enzyme-rich malt extract and a production process designed to preserve that naturally occurring enzyme activity in a practical nutritional format.
The next section looks at why malted barley is such an interesting biological starting material, how germination creates its enzyme system, and how Tharos developed a production approach intended to retain that activity.
A barley grain contains stored nutrients intended to support the growth of a new plant. When germination begins, the grain activates biological machinery capable of mobilising those reserves. That includes the development and activation of a broad natural enzyme system.
Before a young plant can photosynthesise effectively, it depends upon energy and nutrients stored inside the grain. Germination activates systems that help break complex reserves into forms that can be used during early growth. Enzymes are central to that transformation.
The seed contains starch, proteins, structural carbohydrates, lipids, minerals and the biological machinery required for germination.
Water and appropriate conditions initiate germination, activating metabolic pathways needed to support the developing plant.
Enzyme activity helps mobilise the grain's nutritional reserves, acting on starches, proteins and components of plant cell structure.
The soluble components of malt can be extracted to create a concentrated nutritional material containing naturally occurring enzyme activity.
Processing conditions matter. The challenge is to produce a stable and practical extract while retaining meaningful biological enzyme activity.
A germinating grain needs to mobilise different types of stored material. That requires multiple biochemical tools, which is why malt can contain activity from enzymes acting across different nutritional substrates.
This breadth is important to the Tharos approach. The starting material is not built around a single isolated enzyme, but around a naturally developed enzyme system within malted grain.
Enzymes are proteins with structures that can be affected by processing conditions. A production method that creates an attractive malt extract is therefore not automatically the same as one designed to retain enzyme activity.
Tharos' development work has focused on an enzyme-rich malt extract produced using a process designed to preserve naturally occurring digestive enzyme activity.
Germination must create the desired biological and enzymatic characteristics within the malted grain.
Extraction and processing conditions must be managed with biological activity in mind rather than treating the malt solely as a flavour or energy ingredient.
The resulting material must be sufficiently consistent, stable and practical to become part of a repeatable nutritional product.
Understanding malt biology and enzyme activity provides a rationale for the technology. But a plausible mechanism is not the same as evidence of what happens when that technology is used in animals.
That is why Tharos has invested in microbiome analysis, metabolomics, veterinary research, field studies and professional trials across horses and dogs.
Next: Research & Evidence
Animals live within changing diets, environments, routines and populations. Field research asks whether biological signals remain meaningful outside tightly controlled conditions.
Tharos has investigated digestive nutrition using different populations, species, study designs and measurement techniques. No single study is treated as the entire answer. The value comes from asking related questions in different ways.
The published study investigated enzyme-rich malt extract in both leisure horses and adult dogs. Faecal samples were collected before supplementation and again after eight weeks, then analysed using both 16S microbial analysis and SIFT/MS metabolomics.
A retrospective study published in Equine Veterinary Education followed horses receiving EquiNectar as part of management for a range of gastrointestinal presentations, with follow-up over two months.
Retrospective design, small heterogeneous population and additional therapies in some horses mean the results should not be interpreted as proof of treatment efficacy.
At Redwings Horse Sanctuary, 45 horses and ponies were divided between a spring-pasture control group and a group receiving enzyme-rich malt extract alongside spring pasture. Faecal volatile compounds were measured using SIFT/MS.
The study is particularly relevant to Anabiomics because it examined metabolic outputs rather than relying only on a description of bacterial composition.
Thoroughbred racehorses in training remained on their normal feeding programmes while faecal pH was monitored weekly before and during four weeks of supplementation.
No untreated control group was included. The authors describe faecal pH as a potential practical marker and state that comparison with microbiome and metabolome outcomes is required.
Two independently run phases asked UK veterinary professionals, trainers and behaviourists to track dogs during CaniNectar supplementation using repeated observational scoring.
This was an observational programme, not a blinded placebo-controlled trial. Professionals knew the dogs were receiving CaniNectar, so other influences cannot be fully excluded.
A peer-reviewed controlled experiment, a retrospective veterinary study and an observational field programme do not carry identical evidential weight. Nor should they be presented as though they do.
Each design can still contribute something useful. Analytical work can explore mechanism. Controlled comparisons can test biological responses. Field studies can show whether signals appear under real-world conditions. Those observations can then generate better questions for the next experiment.
The wider Tharos evidence base includes additional work in horses and dogs, from microbiome and metabolomic analyses to working-dog studies, independent field programmes and emerging research questions.
Microbial profiles, metabolites and environmental markers allow different parts of the digestive system to be examined through complementary analytical lenses.
Measure what is appropriate to the question.A microbiome can be examined at several levels. We can ask which microorganisms are present, what compounds are being produced, what the local environment looks like and what is being observed in the animal. Those are related questions — but they are not the same question.
Two microbial communities can contain many of the same organisms while operating under different nutritional conditions. Conversely, measurable changes in microbial composition do not automatically tell us what those microorganisms are doing.
Tharos therefore uses different analytical and observational approaches according to the scientific question being asked.
16S ribosomal RNA gene analysis can be used to characterise bacterial communities and compare the relative abundance of different bacterial groups between samples or time points.
Metabolomic analysis examines compounds produced or altered within the biological system. In Tharos research, SIFT/MS has been used to examine volatile compounds within faecal samples.
Short-chain fatty acids and other volatile compounds are among the metabolic products associated with microbial fermentation. Changes in their pattern can provide another window into microbial activity.
Faecal pH is a simple field measurement capable of showing changes in the acidity of faecal material. It can provide useful contextual information when interpreted alongside other biological measures.
Depending upon study design, researchers and professionals may record observable characteristics such as stool or faecal consistency, condition, appetite and other predefined practical outcomes.
Some Tharos programmes have also used structured professional or owner observation to explore behaviour, including measures such as anxiety, reactivity, focus and ability to settle.
One result can become much more informative when considered alongside another. A microbiome profile can indicate which bacterial groups have changed, while metabolomics can examine whether the metabolic environment has changed at the same time.
A simple field measure such as faecal pH can add further context, while structured observations help ask whether any analytical signal is accompanied by something meaningful in the animal.
The aim is not necessarily to make every measure move. It is to build a more complete biological picture.
Different research programmes are designed to answer different questions. A metabolomics experiment may require detailed analytical sampling. A large professional field programme may instead prioritise repeatable observational measures across a much larger population.
The important point is to describe clearly what was measured, how it was measured and what conclusions that study design can reasonably support.
Laboratory measurements can reveal mechanisms and biological signals. Field research helps ask whether those signals remain interesting when animals are living, feeding, training and behaving under everyday conditions.
Microbial and metabolic analysis can investigate the underlying biological system in detail.
Studies in yards, kennels, practices and homes explore responses under practical conditions.
Veterinarians, trainers and other professionals can help identify whether consistent observable patterns emerge.
Tharos uses these tools to understand mechanism, test hypotheses and guide the next stage of product development. The purpose of the science is ultimately to build better nutritional products — not simply to generate more data.
Tharos exists to translate scientific ideas into practical nutritional technologies. That means moving beyond mechanism and measurement into formulation, manufacturing and species-specific product development. The finished product is the final stage of a much longer scientific process.
Begin with a meaningful question about digestion, nutrition or the microbial environment.
Use analytical, controlled and field research to explore whether the biological idea is supported by data.
Formulation and practical use have to reflect the animal, its digestive physiology and how the product will be fed.
Manufacture a repeatable nutritional product capable of being used consistently outside the research environment.
EquiNectar grew from the original equine research programme and became the first major commercial expression of Tharos' enzyme-rich malt technology. It is designed as daily nutritional support within the context of equine digestion.
CaniNectar extended the scientific programme into dogs. The product applies enzyme-rich malt technology within a formulation and feeding approach developed specifically for canine nutrition, digestive physiology and practical use.
Horses and dogs have different gastrointestinal anatomy, feeding behaviour, diets and nutritional requirements. A scientific principle that is relevant across mammals therefore does not imply that the same finished formulation should simply be copied from one species to another.
Species-specific development means considering both the biology and the practical reality of use.
Tharos does not start every development programme by asking how an existing ingredient can be placed into another product. The starting point should remain the biological question.
That is why the wider Tharos portfolio can include different nutritional technologies for different digestive roles. Different questions may require different tools.
Commercial use creates new observations, new populations and new questions. Those questions can lead back into laboratory work, field studies and collaborations — continuing the cycle between science and product development.
Tharos began with a question about digestion and the microbial environment. The research that followed has answered some questions and created many more. That is exactly what a useful scientific programme should do.
A commercial product is not the end point of scientific enquiry. Use in different animals, diets, environments and populations creates new observations that can be investigated more formally.
Those observations can generate new hypotheses, new analytical work and new study designs. The relationship between science and product development is therefore a cycle rather than a straight line.
Identify a biological or nutritional problem worth understanding.
Choose methods capable of testing the question rather than simply confirming an assumption.
Turn useful scientific findings into a practical nutritional technology.
Different animals and environments create new data, observations and unexpected questions.
New observations become the starting point for further research.
The Tharos research programme continues to be shaped by the relationships between nutrition, digestive physiology, microbial communities and observable outcomes.
Further understanding how upstream nutrient processing changes what becomes available further downstream.
Looking beyond microbial composition to investigate metabolic outputs and functional responses.
Connecting analytical findings with practical outcomes observed in animals under everyday conditions.
Scientific progress depends upon combining expertise, facilities, populations and perspectives. Tharos works with researchers, veterinary professionals and other organisations where collaboration can help answer a worthwhile question.
We are interested in research that helps explain mechanism, tests biological responses or improves our understanding of how nutritional technologies perform under real-world conditions.
Explore the wider equine and canine research programmes, meet the people behind Tharos, or contact us to discuss a potential research or development collaboration.